DDX3X and cancer: SGE-depleted variants are also over-represented in cancer types in which DDX3X has not yet been conclusively demonstrated to be a driver gene, suggesting that DDX3X may play a tumour suppressor role in a wider range of cancers than currently appreciated, and that integrating this variant effect map should increase power in analyses of somatic mutation enrichment.